# Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides

> **NCT03281811** · EARLY_PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 11 (actual)

## Conditions studied

- Refractory Mycosis Fungoides

## Interventions

- **DRUG:** Aminolevulinic Acid Hydrochloride
- **DRUG:** Photodynamic Therapy
- **OTHER:** Quality-of-Life Assessment
- **RADIATION:** Radiation Therapy

## Key facts

- **NCT ID:** NCT03281811
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-13
- **Primary completion:** 2020-02-25
- **Final completion:** 2020-08-12
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2023-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03281811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03281811, "Photodynamic Therapy in Treating Patients With Refractory Mycosis Fungoides". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03281811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*